New findings on the reported antidiabetic action of natural fatty acid derivatives published in Cell Metabolism

In a very successful collaboration between the healthcare company Sanofi and our group, a series of natural fatty acids, known as FAHFAs were synthesized and their antidiabetic action was investigated. Contrary to previous reports, it was found that none of these molecules was able to achieve positive effects on clearly defined endpoints in metabolism. In the hope of a constructive discussion on the discrepancy between the two studies, these results have now been published in Cell Metabolism.